| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) |
|
10605.15 | -35.80 | -0.34% |
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pfizer, Inc. (NYSE: PFE)
PFE Technical Analysis
3
| As on 31st Oct 2017 PFE Share Price closed @ 35.06 and we RECOMMEND Buy for LONG-TERM with Stoploss of 33.57 & Buy for SHORT-TERM with Stoploss of 35.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PFE Share Price
| Open | 35.05 | Change | Price | % |
| High | 35.34 | 1 Day | -0.09 | -0.26 |
| Low | 34.10 | 1 Week | 0.00 | 0.00 |
| Close | 35.06 | 1 Month | -1.28 | -3.52 |
| Volume | 22631719 | 1 Year | 2.47 | 7.58 |
| 52 Week High 36.78 | 52 Week Low 30.51 | ||||
NYSE USA Most Active Stocks
| RAI | 65.40 | -2.23% |
| EMC | 29.05 | 0.97% |
| GE | 20.16 | -1.22% |
| AKS | 4.59 | -21.54% |
| PCS | 11.84 | -0.92% |
| AMD | 10.98 | 0.83% |
| WSH | 47.18 | -2.86% |
| JNS | 14.17 | -0.56% |
| XLS | 24.66 | -0.64% |
| SWY | 35.10 | -0.11% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| PFE Daily Charts |
PFE Intraday Charts |
Whats New @ Bazaartrend |
PFE Free Analysis |
|
|
PFE Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 36.21 |
| RESISTANCE | 35.74 |
| SUPPORT | 34.38 |
| SUPPORT | 33.91 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
PFE Target for Month February
| 4th UP TARGET | 40.22 |
| 3rd UP TARGET | 38.57 |
| 2nd UP TARGET | 37.54 |
| 1st UP TARGET | 36.52 |
| 1st DOWN TARGET | 33.6 |
| 2nd DOWN TARGET | 32.58 |
| 3rd DOWN TARGET | 31.55 |
| 4th DOWN TARGET | 29.9 |
PFE Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
PFE Target for Year 2019
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Pfizer, Inc. ( NYSE USA Symbol : PFE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PFE Other Details
| Segment | EQ | |
| Market Capital | 99999997952.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers - Major | |
| Offical website | http://www.pfizer.com | |
PFE Address
 |
235 East 42nd Street New York, NY 10017 United States Phone: 212-733-2323 |
|
PFE Latest News
PFE Business Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. The companyÂ’s Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising AlzheimerÂ’s disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The companyÂ’s Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company primarily offers biopharmaceutical products, including Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service